Literature DB >> 7738162

Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.

P B Iynedjian1, S Marie, A Gjinovci, B Genin, S P Deng, L Buhler, P Morel, G Mentha.   

Abstract

Glucokinase and phosphoenolpyruvate carboxykinase are key enzymes of glucose metabolism in the rat liver. The former is considered to be instrumental in regulating glucose hepatic release/uptake according to the glycaemia level, and cytosolic phosphoenolpyruvate carboxykinase is a major flux-generating enzyme for gluconeogenesis. The level of expression of both enzymes and the regulation of their mRNAs in the human liver cell were investigated. Surgical biopsies of liver from patients undergoing partial hepatectomies and parenchymal hepatocytes derived from the biopsies were used to assay glucokinase, hexokinase and phosphoenolpyruvate carboxykinase activities. Hepatocytes were placed in culture and the actions of insulin, glucagon and cAMP on glucokinase and phosphoenolpyruvate carboxykinase mRNAs were studied. The main results are: (a) glucokinase accounts for 95% of the glucose phosphorylation activity of human hepatocytes, although this fact is masked in assays of total liver tissue; (b) glucokinase activity is set at a lower level in human hepatocytes than in rat hepatocytes, and vice-versa for the gluconeogenic enzyme phosphoenolpyruvate carboxykinase; and (c) as previously shown in rat liver, glucokinase and phosphoenolpyruvate carboxykinase mRNAs are regulated in a reciprocal fashion in human hepatocytes, insulin inducing the first enzyme and repressing the latter, whereas glucagon has opposite effects. These data have interesting implications with respect to metabolic regulation and intracellular hormone signaling in the human liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738162      PMCID: PMC295767          DOI: 10.1172/JCI117880

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

2.  Adaptable glucokinase activity of human liver.

Authors:  B Borrebaek; E Hultman; L H Nilsson; A E Roch-Norlund; O Spydevold
Journal:  Biochem Med       Date:  1970-12

3.  Identification of human hepatic glucokinase and some properties of the enzyme.

Authors:  S J Pilkis
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

4.  Isolation and characterization of the gene coding for cytosolic phosphoenolpyruvate carboxykinase (GTP) from the rat.

Authors:  H Yoo-Warren; J E Monahan; J Short; H Short; A Bruzel; A Wynshaw-Boris; H M Meisner; D Samols; R W Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Hepatic glucose phosphototransferases. Variations among species.

Authors:  V Lauris; G F Cahill
Journal:  Diabetes       Date:  1966-07       Impact factor: 9.461

6.  Regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat liver cells. Rapid induction of specific mRNA by glucagon or cyclic AMP and permissive effect of dexamethasone.

Authors:  A Salavert; P B Iynedjian
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

7.  cAMP stimulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase in rat liver nuclei.

Authors:  W H Lamers; R W Hanson; H M Meisner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Insulin signalling and regulation of glucokinase gene expression in cultured hepatocytes.

Authors:  T Nouspikel; P B Iynedjian
Journal:  Eur J Biochem       Date:  1992-11-15

9.  Increase in level of functional messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) during induction by cyclic adenosine 3':5'-monophosphate.

Authors:  P B Iynedjian; R W Hanson
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

10.  Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin.

Authors:  D Granner; T Andreone; K Sasaki; E Beale
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

View more
  20 in total

1.  Hepatic HKDC1 Expression Contributes to Liver Metabolism.

Authors:  Carolina M Pusec; Adam De Jesus; Md Wasim Khan; Alexander R Terry; Anton E Ludvik; Kai Xu; Nicholas Giancola; Haaris Pervaiz; Emily Daviau Smith; Xianzhong Ding; Stephen Harrison; Navdeep S Chandel; Thomas C Becker; Nissim Hay; Hossein Ardehali; Jose Cordoba-Chacon; Brian T Layden
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

Review 2.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

3.  Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene.

Authors:  P B Iynedjian
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.

Authors:  S D Mittelman; Y Y Fu; K Rebrin; G Steil; R N Bergman
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

5.  Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase.

Authors:  P B Iynedjian; R A Roth; M Fleischmann; A Gjinovci
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 6.  Molecular and cellular regulation of human glucokinase.

Authors:  Shawn M Sternisha; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2019-01-11       Impact factor: 4.013

7.  Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells.

Authors:  Petra Krause; Farahnaz Saghatolislam; Sarah Koenig; Kirsten Unthan-Fechner; Irmelin Probst
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-28       Impact factor: 2.416

8.  Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1) mRNAs in hepatocytes.

Authors:  Pascale G Ribaux; Patrick B Iynedjian
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

9.  Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes.

Authors:  Patrick B Iynedjian
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.